Cargando…
Metformin and the gastrointestinal tract
Metformin is an effective agent with a good safety profile that is widely used as a first-line treatment for type 2 diabetes, yet its mechanisms of action and variability in terms of efficacy and side effects remain poorly understood. Although the liver is recognised as a major site of metformin pha...
Autores principales: | McCreight, Laura J., Bailey, Clifford J., Pearson, Ewan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742508/ https://www.ncbi.nlm.nih.gov/pubmed/26780750 http://dx.doi.org/10.1007/s00125-015-3844-9 |
Ejemplares similares
-
Pharmacokinetics of metformin in patients with gastrointestinal intolerance
por: McCreight, Laura J., et al.
Publicado: (2018) -
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
por: McCreight, Laura J., et al.
Publicado: (2019) -
Quantitative MRI evaluation of whole abdomen adipose tissue volumes in healthy volunteers—validation of technique and implications for clinical studies
por: Marzetti, Matthew, et al.
Publicado: (2018) -
tRNA methyltransferase homologue gene TRMT10A mutation in young adult‐onset diabetes with intellectual disability, microcephaly and epilepsy
por: Yew, T. W., et al.
Publicado: (2016) -
The mechanisms of action of metformin
por: Rena, Graham, et al.
Publicado: (2017)